1.Granchi C, Fancelli D, Minutolo F.. (2014) An update on therapeutic opportunities offered by cancer glycolytic metabolism., 24 (21):[PMID:25288186][10.1016/j.bmcl.2014.09.041]
2.Dragovich PS, Fauber BP, Boggs J, Chen J, Corson LB, Ding CZ, Eigenbrot C, Ge H, Giannetti AM, Hunsaker T, Labadie S, Li C, Liu Y, Liu Y, Ma S, Malek S, Peterson D, Pitts KE, Purkey HE, Robarge K, Salphati L, Sideris S, Ultsch M, VanderPorten E, Wang J, Wei B, Xu Q, Yen I, Yue Q, Zhang H, Zhang X, Zhou A.. (2014) Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase., 24 (16):[PMID:25037916][10.1016/j.bmcl.2014.06.076]
3.Labadie S, Dragovich PS, Chen J, Fauber BP, Boggs J, Corson LB, Ding CZ, Eigenbrot C, Ge H, Ho Q, Lai KW, Ma S, Malek S, Peterson D, Purkey HE, Robarge K, Salphati L, Sideris S, Ultsch M, VanderPorten E, Wei B, Xu Q, Yen I, Yue Q, Zhang H, Zhang X, Zhou A.. (2014) Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase., 25 (1):[PMID:25466195][10.1016/j.bmcl.2014.11.008]
4.Fang A, Zhang Q, Fan H, Zhou Y, Yao Y, Zhang Y, Huang X.. (2017) Discovery of human lactate dehydrogenase A (LDHA) inhibitors as anticancer agents to inhibit the proliferation of MG-63 osteosarcoma cells., 8 (8):[PMID:30108883][10.1039/C7MD00222J]